• N/A
    Market Cap
  • -91.94%
    1-Year Change
  • Medical Devices
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 63
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Baird Medical Enters South Korea Market through Strategic Distribution Partnership with ALLIS MED

Baird Medical announced a strategic distribution partnership with ALLIS MED to serve as Korea License Holder and exclusive distributor of its microwave ablation products in South Korea following regulatory certification. The partnership marks another milestone in Baird Medical's global expansion strategy, with the company having entered multiple new markets in 2026 including Argentina, Egypt, Pakistan, and Vietnam, while also advancing its IRE-based products and AI-powered robotic ablation system.

11/12/2026, 8:00 AM • GlobeNewswire

Baird Medical Announces Regulatory Milestones in Vietnam and Egypt, Expanding International Reach of Microwave Ablation Technology

Baird Medical announced medical device registrations in Vietnam and preliminary regulatory approval in Egypt for its microwave ablation technology. The company received Class C registration certificates in Vietnam for multiple MWA products including needles and generators, while the Egyptian Drug Authority granted preliminary approval for its BD-GT Microwave Ablation System. These milestones support the company's international expansion strategy beyond the U.S. and China markets.

10/19/2026, 8:00 AM • GlobeNewswire

Peers

Statistics

More
Day Range
$0.09
$0.16
$0.10
1-Year Range
$0.09
$3.44
$0.10
Latest Close$0.10
Change
+$0.007 (+6.73%)
Volume151,072,959
Shares Outstanding41.0M
P/E (TTM)-0.11
Diluted EPS (TTM)-$0.98

Information as of 11/11/2026

Company Profile

BAIRD MEDICAL INVESTMENT HOLDINGS LTD
https://bairdmed.com
N/A
Market Cap
-$27.3M
Net Income
Sector: Healthcare
Industry: Medical Devices
Baide Building, Building 11, Guangzhou, China
86 20 8218 5926

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors. It has a strategic cooperation agreement with Tianjin Yuanshan Medical Technology Co., Ltd. to focus on global development and commercialization of next-generation IRE technologies. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.

Key Executives

  • Haimei Wu
  • Quan Qiu
  • Wei Hou
  • Rongjian Lu
  • Mark S. Saxton

Current Ownership Distribution

  • Insiders22.6M (70.50%)
  • Other9.4M (29.31%)
  • Mutual Funds61,900 (0.19%)
  • Institutions0 (0.00%)